Top Markets
#1 Helium Helium +93.49%
#2 MowCat MowCat +84.25%
#3 Seeker Seeker +49.37%
#4 UnifAI Network UnifAI Network +32.18%
#5 TENDIES TENDIES +30.27%
#6 Pons Pons +26.03%
#7 Zylo Ecosystem Zylo Ecosystem +22.35%
#8 Bounce Bounce +18.04%
#9 Tensor Tensor +17.67%
#10 Zora Zora +17.02%
Coin of the day
Helium Helium
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd.

SENORES
Clasificación en acciones #11030
Established in 2017 and headquartered in Ahmedabad, India, Senores... Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
Precio por acción
$16.36
Última sincronización: 2026-08-28
Capitalización bursátil
$753.27M
Cambio (1 día)
0.51%
Cambio (1 año)
108.95%
País
IN
Comercio Senores Pharmaceuticals Ltd. (SENORES)

Categoría

Healthcare
Ganancias de Senores Pharmaceuticals Ltd. (SENORES)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Senores Pharmaceuticals Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Senores Pharmaceuticals Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US